Short- and long-term outcome of patients treated with cyclosporin for severe acute ulcerative colitis.
about
Cyclosporine A for induction of remission in severe ulcerative colitisMedical Therapy of Active Ulcerative ColitisUlcerative colitis.Factors predictive of response to cyclosporin treatment for severe, steroid-resistant ulcerative colitis.Clinical evaluation and management of acute severe colitis.Review article: maintenance of remission in ulcerative colitis.Azathioprine is essential following cyclosporine for patients with steroid-refractory ulcerative colitisReview article: how and when to use ciclosporin in ulcerative colitis.Cyclosporine for severe ulcerative colitis.Immunosuppressive drugs in ulcerative colitis: twisting facts to suit theories?The logics of leukocytapheresis as a natural biological therapy for inflammatory bowel disease.Efficacy of infliximab in acute severe ulcerative colitis: a single-centre experience.Value of colonoscopy for prediction of prognosis in patients with ulcerative colitisEndoscopic findings can predict the efficacy of leukocytapheresis for steroid-naive patients with moderately active ulcerative colitisNocardia asteroides lung abscess in acute ulcerative colitis treated with cyclosporine.In-vitro cyclosporin sensitivity of proliferating lymphocytes is predictive of in-vivo therapeutic response in ulcerative colitis.Positions of selective leukocytapheresis in the medical therapy of ulcerative colitis.Antagonist: Early surgical intervention in ulcerative colitis.Treatment of ulcerative colitis refractory to steroid therapy by oral microemulsion cyclosporine (Neoral).Long-term outcome of treatment with intravenous cyclosporin in patients with severe ulcerative colitis.Granulocytapheresis is useful as an alternative therapy in patients with steroid-refractory or -dependent ulcerative colitis.Long-term results of low-dose intravenous ciclosporin for acute severe ulcerative colitis.Predicting the outcome of severe ulcerative colitis: development of a novel risk score to aid early selection of patients for second-line medical therapy or surgery.
P2860
Q24245067-E35D816E-9E74-4362-AEEC-E5AE1E2B677BQ26777729-C8B38CE8-013A-4443-84E8-A7BDC88F16E2Q33816863-F1CA9C8E-3AD2-4A49-8531-7B25B3445684Q34009451-EE061517-666F-4A24-8E7C-D8676844C0CAQ34015905-B9E86A3F-9B16-4AEF-9701-DBC5E5BB39E6Q34669207-E8AC4B18-23D0-4914-B891-CC206723B36AQ34827381-D9D50F25-DD49-4D3E-9802-73CA1A070694Q36305931-53B69688-3134-4208-A01A-D8AB452BE826Q36348371-5BE53D2C-EBED-43E1-B176-5043E8CE38BCQ36419073-028B9CE2-A819-4A89-B7D6-5833B6E07955Q36446929-C65CF5DC-7352-4EF0-8214-971BB01B3C51Q36637710-9D150EE7-227B-4FCA-8737-627655635F2BQ37136938-4CA2557F-6465-4C29-835D-127DF3237065Q37347061-8F14158B-2D43-41FF-8FA3-7CC1AA3489E1Q40695651-0CC797A0-AFE3-4290-B019-175693435CE4Q40710528-0989EE81-F8B3-43B0-A5B3-AF0DEB7247FEQ42726307-8BB47ACA-0422-484D-8163-4B12C919C981Q43003888-61F93B31-A9C2-49BB-9C52-14CFD23CC3AAQ43658939-A1A4BD6D-14D0-4D04-9112-91A7002A9491Q43798421-AE5A24E9-172C-48D7-A89F-207A72FEAC83Q43963773-29E0363C-6C61-4406-A371-4F9E8D9EEBA4Q44535154-E1CD61FF-1FE0-40D7-B769-FFF13D28C5BAQ54563945-AC0A7E55-FB3B-411D-94BB-DB2406670658
P2860
Short- and long-term outcome of patients treated with cyclosporin for severe acute ulcerative colitis.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh
1998年學術文章
@zh-hant
name
Short- and long-term outcome o ...... vere acute ulcerative colitis.
@en
Short- and long-term outcome o ...... vere acute ulcerative colitis.
@nl
type
label
Short- and long-term outcome o ...... vere acute ulcerative colitis.
@en
Short- and long-term outcome o ...... vere acute ulcerative colitis.
@nl
prefLabel
Short- and long-term outcome o ...... vere acute ulcerative colitis.
@en
Short- and long-term outcome o ...... vere acute ulcerative colitis.
@nl
P2093
P2860
P1476
Short- and long-term outcome o ...... vere acute ulcerative colitis.
@en
P2093
P2860
P304
P356
10.1046/J.1365-2036.1998.00396.X
P407
P577
1998-10-01T00:00:00Z